![Ed Venkat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ed Venkat
Keine laufenden Positionen mehr
Profil
Ed Venkat worked as a Director of Process Development at GlobeImmune, Inc. and as a Director of Pharmaceutical Development at Cleveland BioLabs, Inc. from 2010 to 2011.
He holds a doctorate degree from Rutgers State University of New Jersey, a graduate degree from Stevens Institute of Technology, and a graduate degree from Indian Institute of Technology New Delhi.
Ehemalige bekannte Positionen von Ed Venkat
Unternehmen | Position | Ende |
---|---|---|
GLOBEIMMUNE, INC. | Corporate Officer/Principal | - |
STATERA BIOPHARMA, INC. | Corporate Officer/Principal | - |
Ausbildung von Ed Venkat
Indian Institute of Technology New Delhi | Graduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Stevens Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GLOBEIMMUNE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cleveland BioLabs, Inc.
![]() Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |